JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krismer, A. C.
Right arrow Articles by Strohmenger, H. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krismer, A. C.
Right arrow Articles by Strohmenger, H. U.
Related Collections
Right arrow Resuscitation
Right arrow Pharmacology
Anesth Analg 2001;92:1499-1504
© 2001 International Anesthesia Research Society


CRITICAL CARE AND TRAUMA

The Effects of Endogenous and Exogenous Vasopressin During Experimental Cardiopulmonary Resuscitation

Anette C. Krismer, MD*, Karl H. Lindner, MD*, Volker Wenzel, MD*, Viktoria D. Mayr, MD*, Wolfgang G. Voelckel, MD*, Keith G. Lurie, MD{dagger}, and Hans U. Strohmenger, MD*

*Department of Anesthesiology and Critical Care Medicine, The Leopold-Franzens-University of Innsbruck, Austria; and {dagger}the Cardiac Arrhythmia Center, Cardiovascular Division, Department of Medicine at the University of Minnesota, Minneapolis, Minnesota

Address correspondence to Anette C. Krismer, MD, The Leopold-Franzens-University of Innsbruck, Department of Anesthesiology and Critical Care Medicine, Anichstrasse 35, 6020 Innsbruck, Austria. Address e-mail to anette.krismer{at}uibk.ac.at Address reprint requests to Karl H. Lindner, MD, The Leopold-Franzens-University of Innsbruck, Department of Anesthesiology and Critical Care Medicine, Anichstrasse 35, 6020 Innsbruck, Austria.

Exogenous vasopressin is a promising vasopressor when blood pressure is critically threatened, but the role of endogenous vasopressin during cardiopulmonary resuscitation (CPR) is unknown. We assessed the role of endogenous versus exogenous vasopressin in a porcine open chest CPR model. Seven minutes before induction of cardiac arrest, seven pigs received 10 µg/kg of a selective vasopressin V1-receptor-antagonist (Blocked Vasopressin group); another 12 pigs in two groups received saline administration only. After 4 min of untreated ventricular fibrillation followed by 3 min of basic life support CPR, six animals received 0.8 U/kg vasopressin (Exogenous Vasopressin group), whereas the blocked vasopressin group (n = 7), and the remaining six animals received saline placebo only (Endogenous Vasopressin group). Defibrillation was attempted after 14 min of CPR. During basic life support CPR, left ventricular myocardial blood flow was significantly (P < 0.05) decreased in the Blocked Vasopressin group compared with the Exogenous Vasopressin group and Endogenous Vasopressin group (42 ± 5 compared with 64 ± 6 and 66 ± 6 mL · min-1 · 100g-1). Left ventricular myocardial blood flow was significantly decreased in the Blocked Vasopressin group versus Exogenous Vasopressin group versus Endogenous Vasopressin group 90 s and 5 min after drug administration, respectively (38 ± 4 and 27 ± 3 vs 145 ± 32 and 110 ± 12 vs 62 ± 4 and 56 ± 6 mL · min-1 · 100g-1, respectively). None of seven Blocked Vasopressin animals, six of six Exogenous Vasopressin pigs, and six of six Endogenous Vasopressin swine had return of spontaneous circulation after 14 min of cardiac arrest including 10 min of CPR (P < 0.05). In conclusion, pigs with blocked endogenous vasopressin had poor coronary perfusion pressure and left ventricular myocardial blood flow during open chest CPR, and could not be successfully resuscitated. All pigs with effective endogenous vasopressin or pigs with effective endogenous vasopressin and additional exogenous vasopressin had good left ventricular myocardial blood flow during experimental CPR, and survived the 1-h postresuscitation phase. We conclude that endogenous vasopressin is an adjunct vasopressor to epinephrine and may serve as a back-up regulator to maintain cardiocirculatory homeostasis.

Implications: The study was designed to assess the role of endogenous versus exogenous vasopressin in a porcine cardiopulmonary resuscitation (CPR) model. Only pigs with effective endogenous vasopressin, or pigs with effective endogenous vasopressin and administration of exogenous vasopressin had good left ventricular myocardial blood flow during experimental CPR, had return of spontaneous circulation after defibrillation and survived the 1-h postresuscitation phase.




This article has been cited by other articles:


Home page
Am J Crit CareHome page
J. Heath, D. Hanson, R. Long, and N. A. Crowell
Critical Care Providers' Perceptions of the Use of Vasopressin in Cardiac Arrest
Am. J. Crit. Care., November 1, 2005; 14(6): 481 - 492.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2001 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.